| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 05/23/2002 | CA2749307A1 Promoter sequence of a gene encoding an exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2707684A1 Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2632696A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2467360A1 Exoenzyme toxin of aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2467309A1 Type iii secretion pathway in aeromonas salmonicida, and uses therefor |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429210A1 Expression system for recombinant proteins |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429142A1 Maize yellow stripe1 and related genes |
| 05/23/2002 | CA2429140A1 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 05/23/2002 | CA2428693A1 In vitro protein synthesis using glycolytic intermediates as an energy source |
| 05/23/2002 | CA2428643A1 Methods for large scale protein production in prokaryotes |
| 05/23/2002 | CA2428136A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2427010A1 Transporters and ion channels |
| 05/23/2002 | CA2426100A1 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 05/22/2002 | EP1207200A1 High affinity choline transporter |
| 05/22/2002 | EP1207198A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206561A2 Method for production of proteinaceous substances |
| 05/22/2002 | EP1206554A1 Activatable recombinant neurotoxins |
| 05/22/2002 | EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206540A2 Dna sequences isolated from human colonic epithelial cells |
| 05/22/2002 | EP1206535A1 Tumor-associated antigen (r11) |
| 05/22/2002 | EP1206530A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 05/22/2002 | EP1206495A1 Chimeric polypeptides, method for production and uses thereof |
| 05/22/2002 | EP1206493A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 05/22/2002 | EP1206492A2 Self-aligning peptides derived from human elastin and other fibrous proteins |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206487A2 Notch receptor ligands and uses thereof |
| 05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 05/22/2002 | EP1123004B1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 05/22/2002 | EP1107996B1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 05/22/2002 | EP0929564A4 High level expression of proteins |
| 05/22/2002 | EP0720623B1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors |
| 05/22/2002 | EP0452364B1 Method for preparing water soluble polypeptides |
| 05/22/2002 | CN1350584A Process for producing recombinant insulain from novel fused protein |
| 05/22/2002 | CN1350582A Method for generating split, non-transferable genes that are able to express an active protein product |
| 05/22/2002 | CN1350549A Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
| 05/22/2002 | CN1085249C production of variant nisin |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392027 Mammalian adrenocorticotropic hormone receptor nucleic acids |
| 05/21/2002 | US6392026 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 05/21/2002 | US6392023 Nucleotide sequences which codes preferential polypeptide for use in serodiagnostics and vaccine development |
| 05/21/2002 | US6392020 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical compostion and a diagnostic reagent comprising the same |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392014 Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications |
| 05/21/2002 | US6392013 Redirection of cellular immunity by protein tyrosine kinase chimeras |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391852 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/21/2002 | US6391634 Monoclonal antibodies and their production and use |
| 05/21/2002 | US6391633 Genetically engineered cells for use as tools in the expression of heterologous genes |
| 05/21/2002 | US6391589 Human chemokine beta-10 mutant polypeptides |
| 05/21/2002 | US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals |
| 05/21/2002 | US6391585 Plasmid for use as tool in generation of genetic engineering heterologous proteins |
| 05/21/2002 | US6391581 DNA encoding interleukin-4 receptors |
| 05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
| 05/21/2002 | US6391569 Method to detect Dirofilaria immitis infection |
| 05/21/2002 | US6391566 Drug screening of ligands which interact with receptor of defined amino acid sequence incubating by incubating ligand with recombinant cell or membrane which expresses receptor |
| 05/21/2002 | US6391565 Methods of detecting growth differentiation factor-3 |
| 05/21/2002 | US6391563 Method for the determination of antigens with the aid of three or more monoclonal antibodies |
| 05/21/2002 | US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences |
| 05/21/2002 | US6391315 Composition comprising mixed antigens derived from both cell surface extracts and cultured broth, treated by chromatography to obtain effective fraction free of endotoxin and whole cells |
| 05/21/2002 | US6391311 Polypeptide comprising amino acid sequence at least about 80% identical to specified sequence, which has biological activity of promoting selective growth and/or survival of human umbilical vein endothelial cells in in vitro assay |
| 05/21/2002 | US6391299 Anti-factor IX/IXa antibodies |
| 05/21/2002 | CA2183241C Yeast strains and modified albumins |
| 05/21/2002 | CA2037664C Monoclonal antibody against complexed and noncomplexed complexing agents for removing heavy metals from aqueous solutions and for analysis |
| 05/21/2002 | CA1341361C Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 05/16/2002 | WO2002039123A1 Kit and method for detecting the esm-1 protein |
| 05/16/2002 | WO2002039120A1 A method for identifying the proteome of cells using an antibody library microarray |
| 05/16/2002 | WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 05/16/2002 | WO2002038790A1 Process for producing germ extract |
| 05/16/2002 | WO2002038766A2 Human tumor necrosis factor receptor |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038610A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | WO2002038609A2 Apolipoprotein conjugates |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/16/2002 | WO2002038580A1 Streptavidin-binding peptides and uses thereof |
| 05/16/2002 | WO2002037967A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 05/16/2002 | WO2002004512A3 Purification of human troponin i |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2001092469A3 Phosphorylated polypeptides and uses related thereto |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001044299A3 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001029255A3 Diagnostic test for cephalic pain |
| 05/16/2002 | US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058792 Method for solubilization and naturation of somatotropins |
| 05/16/2002 | US20020058791 Hybrid cytokine of IL-7 and beta-chain of hepatocyte growth factor |